Adrixetinib
N-[5-(6,7-dimethoxyquinolin-4-yl)oxy-2-pyridinyl]-1-propyl-4-(2,2,2-trifluoroethoxy)pyrazole-3-carboxamide
Molecular Identity
Adrixetinib
N-[5-(6,7-dimethoxyquinolin-4-yl)oxy-2-pyridinyl]-1-propyl-4-(2,2,2-trifluoroethoxy)pyrazole-3-carboxamide
PubChem CID: 156440741
2D Structure
Properties
C25H24F3N5O5
Molecular Formula
531.50
Molecular Weight
g/mol
531.1730
Exact Mass
Da
4.3
XLogP
Drug-like (Lipinski: < 5)
110
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
11
H-Bond Acceptors
765
Complexity
SMILES
Canonical SMILES
SMILES: CCCN1C=C(C(=N1)C(=O)NC2=NC=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)OCC(F)(F)FIsomeric SMILES
SMILES: CCCN1C=C(C(=N1)C(=O)NC2=NC=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)OCC(F)(F)FSynonyms(20)
Adrixetinib2394874-66-7N-[5-(6,7-dimethoxyquinolin-4-yl)oxypyridin-2-yl]-1-propyl-4-(2,2,2-trifluoroethoxy)pyrazole-3-carboxamideN-{5-[(6,7-Dimethoxyquinolin-4-yl)oxy]pyridin-2-yl}-1-propyl-4-(2,2,2-trifluoroethoxy)-1H-pyrazole-3-carboxamideadrixetinib [INN]Adrixetinib [WHO-DD]JIJ7I9XO8Borb1739829CHEMBL5314452SCHEMBL23456979SCHEMBL31614098GTPL12375GLXC-26812EX-A8325example 7 [US2021163448A1]
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Adrixetinib
Loading drug network...